Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology

Dr James McCracken

Declaration of Interests

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No
  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No
  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No
  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. Roche: received consultant income for contributions to study design and interpretation of results, and for attendance at Advisory Board to discuss clinical measures for autism trials Alcobra: Received payment for serving as a DSMB member Pharmanet: received consultant payments for serving as DSMB member for Janssen clinical trial
  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. received payment for services as expert witness for Kremers Urban
  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. Held research contracts for clinical trials with Roche and Psyadon Pharmaceuticals
  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No
  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No
  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. Received travel support for Roche Advisory Board
  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. Performed clinical trials under research contracts from Roche for autism studies and Psyadon for Tourette Syndrome study.
  21. If there is anything else you feel it necessary to disclose, please provide details below:

Form completed on 16th January 2018